ReviewMedical sciences (Basel, Switzerland)2018

New Insights into Development of Transglutaminase 2 Inhibitors as Pharmaceutical Lead Compounds.

Soo-Youl KimPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.